KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zimmer Biomet Holdings (ZBH) Gains from Sales and Divestitures (2022 - 2025)

Zimmer Biomet Holdings has reported Gains from Sales and Divestitures over the past 6 years, most recently at $683000.0 for Q4 2025.

  • For Q4 2025, Gains from Sales and Divestitures rose 68.64% year-over-year to $683000.0; the TTM value through Dec 2025 reached $683000.0, up 68.64%, while the annual FY2025 figure was $683000.0, 68.64% up from the prior year.
  • Gains from Sales and Divestitures for Q4 2025 was $683000.0 at Zimmer Biomet Holdings, up from $405000.0 in the prior quarter.
  • Over five years, Gains from Sales and Divestitures peaked at $683000.0 in Q4 2025 and troughed at $168000.0 in Q4 2022.
  • A 4-year average of $380250.0 and a median of $335000.0 in 2023 define the central range for Gains from Sales and Divestitures.
  • Biggest five-year swings in Gains from Sales and Divestitures: skyrocketed 52.83% in 2024 and later soared 68.64% in 2025.
  • Year by year, Gains from Sales and Divestitures stood at $168000.0 in 2022, then skyrocketed by 57.74% to $265000.0 in 2023, then skyrocketed by 52.83% to $405000.0 in 2024, then soared by 68.64% to $683000.0 in 2025.
  • Business Quant data shows Gains from Sales and Divestitures for ZBH at $683000.0 in Q4 2025, $405000.0 in Q4 2024, and $265000.0 in Q4 2023.